Axonics, Inc.Axonics, Inc.Axonics, Inc.

Axonics, Inc.

No trades
See on Supercharts
Market capitalization
‪3.42 B‬USD
−0.13USD
‪−6.09 M‬USD
‪366.38 M‬USD
‪50.44 M‬
Beta (1Y)
1.48

About Axonics, Inc.

CEO
Raymond Wayne Cohen
Headquarters
Irvine
Employees (FY)
797
Founded
2012
ISIN
US05465P1012
FIGI
BBG0067QVJ50
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AXNX is 66.95 USD — it has decreased by 0.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Axonics, Inc. stocks are traded under the ticker AXNX.
Axonics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
AXNX stock is 0.41% volatile and has beta coefficient of 1.48. Check out the list of the most volatile stocks — is Axonics, Inc. there?
One year price forecast for Axonics, Inc. has a max estimate of 75.00 USD and a min estimate of 71.00 USD.
AXNX earnings for the last quarter are 0.08 USD per share, whereas the estimation was −0.05 USD resulting in a 256.71% surprise. The estimated earnings for the next quarter are 0.06 USD per share. See more details about Axonics, Inc. earnings.
Axonics, Inc. revenue for the last quarter amounts to ‪93.10 M‬ USD despite the estimated figure of ‪89.59 M‬ USD. In the next quarter revenue is expected to reach ‪107.33 M‬ USD.
Yes, you can track Axonics, Inc. financials in yearly and quarterly reports right on TradingView.
AXNX stock has fallen by 1.18% compared to the previous week, the month change is a 2.45% fall, over the last year Axonics, Inc. has showed a 14.41% increase.
AXNX net income for the last quarter is ‪6.57 M‬ USD, while the quarter before that showed ‪3.93 M‬ USD of net income which accounts for 67.36% change. Track more Axonics, Inc. financial stats to get the full picture.
Today Axonics, Inc. has the market capitalization of ‪3.42 B‬, it has decreased by 1.74% over the last week.
No, AXNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AXNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Axonics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AXNX reached its all-time high on Sep 15, 2022 with the price of 79.92 USD, and its all-time low was 11.95 USD and was reached on Nov 30, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 797.00 employees. See our rating of the largest employees — is Axonics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Axonics, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Axonics, Inc. stock shows the buy signal. See more of Axonics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Axonics, Inc. future price: according to them, AXNX price has a max estimate of 75.00 USD and a min estimate of 71.00 USD. Read a more detailed Axonics, Inc. forecast: see what analysts think of Axonics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Axonics, Inc. EBITDA is ‪8.68 M‬ USD, and current EBITDA margin is 2.37%. See more stats in Axonics, Inc. financial statements.